Structured Summary
Abstract
A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
8 entry terms
- CDKN1C Protein
- Cyclin Kinase Inhibitor Protein 2
- Cyclin-Dependent Kinase Inhibitor 1C
- p57 KIP2 Protein
- p57KIP2 Protein
- Cyclin Dependent Kinase Inhibitor 1C
- Cyclin Dependent Kinase Inhibitor p57
- KIP2 Protein, p57
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2006(1995)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Cyclin-Dependent Kinase Inhibitor p57. Medical Subject Headings (MeSH). 2026. Unique ID D050761. http://id.nlm.nih.gov/mesh/2026/D050761
- Cyclin-Dependent Kinase Inhibitor p57. In: Wikidata. https://www.wikidata.org/wiki/Q5198257